Results 141 to 150 of about 209,238 (297)
ESC Heart Failure, EarlyView.Impact of empagliflozin in patients with and without T2D or CKD in the EMPACT‐MI trial. Baseline characteristics, HF outcomes and subgroup analysis of efficacy endpoints are shown. # Hazard ratios estimated via Cox proportional hazard model (unless indicated otherwise). ^ Rate ratios via negative binomial regression.
Francesco Fioretti +23 more
wiley +1 more source
D-43 | Restenosis and Outcomes Following PCI of Small Vessels in Cardiac Transplant Recipients [PDF]
Malika Elhage Hassan +10 more
openalex +1 more source
The PCI domains are “winged” HEAT domains [PDF]
, 2022 Eleanor Elise Paul, Assen Marintchev
openalex +1 more source
ESC Heart Failure, EarlyView.The pulsatile ventricular assist platform (pVAP) was connected to a membrane pump in six large swine models. The system, driven by a conventional intra‐aortic balloon pump console (IABP), was utilized to drain left atrial blood during systole and to eject the collected blood back into the ascending aorta during diastole.
Sara Knigge +11 more
wiley +1 more source
ESC Heart Failure, EarlyView.Using EndoWings™ and XDROP™, we developed a percutaneous minimally invasive technique for sequential circumferential alginate hydrogel injection into LV free mid‐wall. This human study assessed its safety/feasibility in HFrEF patients, with personalised biomechanical models.
Bo Wang +13 more
wiley +1 more source
Long‐term prognosis of pure and impure tachycardiomyopathy
ESC Heart Failure, EarlyView.Abstract Background and aims Tachycardia‐induced cardiomyopathy (TCM) is a reversible form of heart failure (HF) driven by arrhythmias, often atrial fibrillation (AF). While reversible, TCM's long‐term prognosis remains unclear, especially in comparison to HF with reduced ejection fraction (HFrEF).
Giulia Stronati +11 more
wiley +1 more source
ESC Heart Failure, EarlyView.Patients with AMI‐CS (lactate >3 mmol/L) enrolled in the multicentre, randomized ECLS‐SHOCK trial were included. From a total of 417 patients, 51.6% (n = 215), 13.4% (n = 56) and 35.0% (n = 146) presented in SCAI Stages C, D and E, respectively. SCAI stages were associated with the risk of 30 day all‐cause mortality, with rates of renal replacement ...
Janine Pöss +13 more
wiley +1 more source
急性心筋梗塞による心停止後症候群に対する緊急PCIの効果(3.「蘇生と救急心血管治療の国際ガイドライン2010」を活かす,<特集II>第76回日本循環器学会学術集会)
, 2013 立花 栄三 +5 more
openalex +2 more sources